Johnson & Johnson says artificial intelligence is reducing by 50% the time needed to generate early drug development leads, accelerating…
Browsing: Drug Development
Pharmaceutical companies are increasingly using artificial intelligence to accelerate clinical trials and regulatory submissions, even as AI has yet to…
U.S. biotech startup Nabla Bio has expanded its collaboration with Japanese pharmaceutical giant Takeda, signing a new multi-year agreement to…
AstraZeneca has entered into a significant AI-driven research partnership with China’s CSPC Pharmaceutical Group worth up to $5.3 billion. The…
Merck (MRK.N) has entered a licensing agreement worth up to $2 billion with Chinese biotech firm Hansoh Pharma (3692.HK) for…
Breakthrough in Itch Treatment for Autoimmune Disease GSK (GlaxoSmithKline) announced on Tuesday that its experimental drug, linerixibat, successfully met its…